TP53 and head and neck squamous cell carcinoma: PF-04691502 has produced significant radiosensitization in nonmetastatic HNSCC xenografts.321 The study demonstrated that radiosensitization in all HNSCC cell lines was identified regardless of p53, and treatment with PF-04691502 downregulated radiosensitization in normal fibroblasts compared with tumor cells.